Stocktoria
BRUKER CORP BRKR
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2000-08-04
BRUKER CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.4B | $3.4B | $3.0B | $2.5B | $2.4B |
| Gross profit | $1.6B | $1.6B | $1.5B | $1.3B | $1.2B |
| R&D expense | $395.2M | $376.5M | $294.8M | $235.9M | $220.8M |
| SG&A expense | $946.5M | $893.8M | $729.4M | $607.4M | $561.2M |
| Operating income | $68.2M | $253.1M | $436.9M | $432.7M | $413.3M |
| Interest expense | — | — | $16.4M | $16.1M | $14.3M |
| Income tax | $29.3M | $91.4M | $117.7M | $116.4M | $113.0M |
| Net income | -$8.6M | $113.1M | $427.2M | $296.6M | $277.1M |
| EPS (diluted) | $-0.15 | $0.76 | $2.90 | $1.99 | $1.81 |
| Operating cash flow | $134.1M | $251.3M | $350.1M | $274.4M | $282.4M |
| Free cash flow | $43.3M | $136.0M | $243.2M | $145.2M | $190.4M |
| Cash & equivalents | $298.8M | $183.4M | $488.3M | $645.5M | $1.1B |
| Inventory | $1.1B | $1.1B | $968.3M | $800.1M | $710.1M |
| Total assets | $6.2B | $5.8B | $4.2B | $3.6B | $3.6B |
| Total liabilities | $3.7B | $4.0B | $2.8B | $2.5B | — |
| Shareholders' equity | $2.5B | $1.8B | $1.4B | $1.1B | $1.1B |
Source: SEC EDGAR filings · CIK 0001109354 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.